As of 2025-06-16, the Relative Valuation of Rocket Pharmaceuticals Inc (RCKT) is (31.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.93 USD, the upside of Rocket Pharmaceuticals Inc based on Relative Valuation is -1158.5%.
The range of the Relative Valuation is (18.97) - (43.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 18.3x | 12.7x |
| Forward P/E multiples | 7.9x - 20.9x | 13.2x |
| Fair Price | (18.97) - (43.92) | (31.01) |
| Upside | -747.4% - -1599.1% | -1158.5% |
| Date | P/E |
| 2025-06-13 | -1.22 |
| 2025-06-12 | -1.28 |
| 2025-06-11 | -1.27 |
| 2025-06-10 | -1.32 |
| 2025-06-09 | -1.26 |
| 2025-06-06 | -1.28 |
| 2025-06-05 | -1.16 |
| 2025-06-04 | -1.22 |
| 2025-06-03 | -1.24 |
| 2025-06-02 | -1.16 |
| 2025-05-30 | -1.05 |
| 2025-05-29 | -1.09 |
| 2025-05-28 | -1.04 |
| 2025-05-27 | -0.97 |
| 2025-05-23 | -2.62 |
| 2025-05-22 | -2.74 |
| 2025-05-21 | -2.75 |
| 2025-05-20 | -2.86 |
| 2025-05-19 | -2.69 |
| 2025-05-16 | -2.71 |
| 2025-05-15 | -2.81 |
| 2025-05-14 | -2.53 |
| 2025-05-13 | -2.76 |
| 2025-05-12 | -2.92 |
| 2025-05-09 | -2.92 |
| 2025-05-08 | -2.94 |
| 2025-05-07 | -2.80 |
| 2025-05-06 | -2.63 |
| 2025-05-05 | -3.28 |
| 2025-05-02 | -3.34 |
| 2025-05-01 | -3.28 |
| 2025-04-30 | -3.19 |
| 2025-04-29 | -3.04 |
| 2025-04-28 | -2.99 |
| 2025-04-25 | -3.02 |
| 2025-04-24 | -3.10 |
| 2025-04-23 | -2.98 |
| 2025-04-22 | -2.91 |
| 2025-04-21 | -2.99 |
| 2025-04-17 | -2.64 |
| 2025-04-16 | -2.57 |
| 2025-04-15 | -2.73 |
| 2025-04-14 | -2.47 |
| 2025-04-11 | -2.20 |
| 2025-04-10 | -2.06 |
| 2025-04-09 | -2.25 |
| 2025-04-08 | -2.00 |
| 2025-04-07 | -2.17 |
| 2025-04-04 | -2.14 |
| 2025-04-03 | -2.32 |